Table 8.
Stelara (ustekinumab) [25]
Initial Visit:
History and Physical
· History of malignancy or serious infections (hepatitis, TB, HIV, other)?
· Total body skin exam for skin cancer
· Check for HSM, cervical/axillary/inguinal lymphadenopathy
· Active infection? Hold dose for infection or sepsis
· Coronary artery disease or stroke?
· Have you lived in Southwest (risk of coccidiomycosis) or Southeast – Ohio and Mississippi River Valleys (risk of histoplasmosis or blastomycosis)?
· Travel to area endemic for TB?
· Live vaccine within past month – you or household member?
· Medications: warfarin; cyclosporine (can alter blood levels)
· Major surgery in next month?
· Latex allergy?
Labs
· CBC, CMP
· TB test (for PPD, consider >5mm as positive)
· Hepatitis B screen: Hepatitis B sAg, Hepatitis B sAb, Hepatitis B cAb
· Influenza vaccine (if flu season)
· HIV (optional) – especially with erythrodermic psoriasis
· Cardiovascular risk panel: CRP, homocysteine, HbA1C, lipid profile (if screening for psoriasis) (optional)
· Pneumovax (optional)
Counseling/Other
· Injections under supervision of health care professional
· Can worsen existing malignancies
· Increased risk of malignancy (non-melanoma skin cancer, breast, colon, head and neck, kidney, prostate, and thyroid cancers)
o History of prior phototherapy - increased risk for non-melanoma skin cancer
· Risk of bacterial, mycobacterial, fungal, and viral infections
· Risk of coronary artery thrombosis/ischemic heart disease
· Theoretical risk for infection from: mycobacteria, salmonella, Bacillus Calmette-Guerin vaccinations
· Risk of reactivation of latent infection (i.e., TB or Hepatitis B)
· No BCG vaccine one year prior to first dose or before one year after last dose
· Reversible Posterior Leukoencephalopathy Syndrome (headache, seizure, confusion, visual disturbance)
· Avoid live vaccines – self and household members
· Pediatric Patients: Up to date on vaccines before starting?
· Needle cap of the prefilled syringe and the autoinjector contain a latex derivative
· Formation of anti-Stelara antibodies that can cause decreased efficacy over time
Follow-up Visit:
History and Physical
· Every six months: Total body skin exam for skin cancer
· Every six months: Check for HSM, cervical/axillary/inguinal lymphadenopathy
· Any new infection – hold dose for active infection or sepsis
· Major surgery in next month?
· Is there sustained clinical efficacy in the treatment interval? Skin? Joints?
· Any live vaccines in past month?
· Any household members getting live vaccine?
· Other interval history
Labs
· Prior to each injection: CBC, CMP
· Every year: TB test (consider induration of >5mm as positive)
· Influenza vaccine annually (in flu season)
· In HBV carriers, check liver panel for laboratory signs of hepatitis B reactivation